Low-molecular-weight heparin in the treatment of recurrent IVF–ET failure and thrombophilia: A prospective randomized placebo-controlled trial

References

• Azem F., Many A., Yovel I., Amit A., Lessing J. B., Kupferminc M. J. Increased rates of thrombophilia in women with repeated IVF failure. Human Reproduction 2004; 19: 368–370
   PubMed Web of Science ®Google Scholar
• Balasch J., Creus M., Fabregues F., Reverter J., Carmona F., Tassies D., et al. Antiphospholipid antibodies in women having in-vitro fertilization. Human Reproduction 1996; 11: 1185–1189
   PubMedGoogle Scholar
• Brenner B., Bar J., Ellis M., Yarom I., Yohai D., Samueloff A. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: Results from the Live-Enox study. Fertility & Sterility 2005; 84: 770–773
   PubMed Web of Science ®Google Scholar
• Chamley L. W., Duncalf A. M., Mithchell M. D., Johnson P. M. Action of anticardiolipin and antibodies to beta 2-glycoprotein-1 on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 1037–1038
   PubMed Web of Science ®Google Scholar
• Clark D. A., Chaouat G., Arck P. C., Mittruecker H. W., Levy G. A. Cytokines-dependent abortion in CBA X DBA/2 mice is mediated procoagulant fgl2 prothrombinase. Journal of Immunology 1998; 160: 545–549
   PubMed Web of Science ®Google Scholar
• Coskun S., Roca G. L., Elnour A., al Mayman H., Hollanders J. M., Jaroudi K. A. Effect of reducing insemination time in human in vitro fertilization and embryo development by using sibling oocytes. Journal of Assisted Reproduction & Genetics 1998; 15: 605–608
   PubMedGoogle Scholar
• Coulam C. B., Krysa L. W., Bustillo M. Intravenous immunoglobulin for in-vitro fertilization failure. Human Reproduction 1994; 9: 2265–2269
   PubMed Web of Science ®Google Scholar
• Coulam C. B., Kaider B. D., Kaider A. S., Janowicz P., Roussev R. G. Antiphospholipid antibodies associated with implantation failure after IVF/ET. Journal of Assisted Reproduction & Genetics 1997; 14: 603–608
   PubMed Web of Science ®Google Scholar
• Ermel L., Marshburn P., Kutteh W. Interaction of heparin with antiphospholipid antibodies from sera of women with recurrent pregnancy loss. American Journal of Reproductive Immunology 1995; 33: 14–20
   PubMedGoogle Scholar
• Friedler K., Wurfel W. Effectivity of heparin in assisted reproduction. European Journal of Medical Research 2004; 30: 207–214
   Google Scholar
• Geva E., Amit A., Lerner-Geva L., Azem F., Yovel I., Lessing J. B. Autoimmune disorders: Another possible cause for in-vitro fertilization and embryo transfer failure. Human Reproduction 1995; 10: 2560–2563
   PubMed Web of Science ®Google Scholar
• Geva E., Amit A., Lerner-Geva L., Yaron Y., Daniel Y., Schwartz T., et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: A prospective study. American Journal of Reproductive Immunology 2000; 43: 36–40
   PubMed Web of Science ®Google Scholar
• Gordis L. Epidemiology2nd ed. W. B. Saunders Company, London 2000
   Google Scholar
• Grandone E., Colaizzo D., Lo Bue A., Checola M. G., Cittadini E., Margaglione M. Inherited thrombophilia and in vitro fertilization implantation failure. Fertility & Sterility 2001; 76: 201–202
   PubMed Web of Science ®Google Scholar
• Greer I. A., De Swiet M. Thrombosis prophylaxis in obstetrics and gynecology. British Journal of Obstetrics & Gynaecology 1993; 100: 37–40
   PubMedGoogle Scholar
• Greer I. A., Nelson-Piercy C. Low-molecular-weight heparin for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005; 106: 401–407
   PubMed Web of Science ®Google Scholar
• Kaider B., Price D., Roussev R., Coulam C. Antiphospholipid antibody prevalence in patients with IVF failure. American Journal of Reproductive Immunology 1996; 35: 388–393
   PubMed Web of Science ®Google Scholar
• Kujovich J. L. Thrombophilia and pregnancy complications. American Journal of Obstetrics & Gynecology 2004; 191: 412–424
   PubMed Web of Science ®Google Scholar
• Kupferminc M. J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of the genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine 1999; 340: 9–13
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J. Y., Chung-Bang H. S., Ng S. C., Ntrivalas E. I., Mangubat C. P., Beaman K. D., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Human Reproduction 2003; 18: 767–773
   PubMed Web of Science ®Google Scholar
• Mak I. Y., Brosens J. J., Christian M., Hills F. A., Chamley L., Regan L., White J. O. Regulated expression of signal transducer and activator of transcription, Stat5 and its enhancement of PRL expression in human endometrial stromal cells. Journal of Clinical Endocrinology & Metabolism 2002; 87: 2581–2588
   PubMedGoogle Scholar
• Martinelli L., Taioli E., Ragni G., Levi-Setti P., Passamonti S. M., Battaglioli T., et al. Embryo implantation after assisted reproductive procedure and maternal thrombophilia. Haematologica 2003; 88: 789–793
   PubMed Web of Science ®Google Scholar
• Qublan H. S., Eid S. S., Ababneh H. A., Amarin Z. O., Smadi A. Z., Al-Khafaji F. F., Khader Y. S. Acquired and inherited thrombophilia: Implication in recurrent IFV and embryo transfer failure. Human Reproduction 2006a; 21: 2694–2698
   PubMed Web of Science ®Google Scholar
• Qublan H. S., Amarin Z., Tahat Y. A., Smadi A. Z., Kilani M. Ovarian cyst formation following GnRH agonist administration in IVF cycles: Incidence and impact. Human Reproduction 2006b; 21: 640–644
   PubMed Web of Science ®Google Scholar
• Quenby S., Mountfield S., Cartwright J. E., Whitley G. S., Chamley L., Vince G. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertility & Sterility 2005; 83: 691–698
   PubMed Web of Science ®Google Scholar
• Sanson B. J., Lensing A. W., Prins M. H., Ginsberg J. S., Barkagam Z. S., Lavenne-Pardonge E., et al. Safety of low-molecular-weight heparin in pregnancy: A systematic review. Thrombosis & Haemostasis 1999; 81: 668–672
   PubMed Web of Science ®Google Scholar
• Sher G., Feinman M., Zouves C., Kuttner G., Maassarani G., Salem R., et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Human Reproduction 1994; 9: 2278–2283
   PubMed Web of Science ®Google Scholar
• Sher G., Matzner W., Feinman M., Maassarani G., Zouves C., Chong P., Ching W. The selective use heparin/aspirin, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology 1998; 40: 74–82
   PubMed Web of Science ®Google Scholar
• Warkentin T. E., Levine M. N., Hirsch J., Horswood P., Roberts R. S., Gent M., Kelton J. G. Heparin induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine 1995; 332: 1330–1335
   PubMed Web of Science ®Google Scholar